Cargando…
Circulating nucleic acids in the plasma and serum as potential biomarkers in neurological disorders
Neurological diseases are responsible for approximately 6.8 million deaths every year. They affect up to 1 billion people worldwide and cause significant disability and reduced quality of life. In most neurological disorders, the diagnosis can be challenging; it frequently requires long-term investi...
Autores principales: | Bruno, D.C.F., Donatti, A., Martin, M., Almeida, V.S., Geraldis, J.C., Oliveira, F.S., Dogini, D.B., Lopes-Cendes, I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446710/ https://www.ncbi.nlm.nih.gov/pubmed/32813850 http://dx.doi.org/10.1590/1414-431X20209881 |
Ejemplares similares
-
Role of non-coding RNAs in non-aging-related neurological
disorders
por: Vieira, A.S., et al.
Publicado: (2018) -
Circulating Metabolites as Potential Biomarkers for Neurological Disorders—Metabolites in Neurological Disorders
por: Donatti, Amanda, et al.
Publicado: (2020) -
Lithium carbonate and coenzyme Q10 reduce cell death in a cell model of Machado-Joseph disease
por: Lopes-Ramos, C.M., et al.
Publicado: (2016) -
Neuroproteomics in Epilepsy: What Do We Know so Far?
por: do Canto, Amanda M., et al.
Publicado: (2021) -
Multi‐omic strategies applied to the study of pharmacoresistance in mesial temporal lobe epilepsy
por: Bruxel, Estela M., et al.
Publicado: (2021)